Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End User & Region - Global Forecast to 2028

Abstract
The global flow cytometry market is projected to reach USD 7.0 billion by 2028 from USD 4.7 billion in 2023, at a CAGR of 8.3% during the forecast period. The rising prevalence of HIV/AIDS, cancer & autoimmune diseases globally is rising adoption of flow cytometry for clinical applications are some of the major factors projecting segmental growth. Additionally, the launch of technologically advanced flow cytometry products by key market players is furthermore likely to propel the market growth. In November 2021, Bio-Rad Laboratories, Inc. (US) launched StarBright UltraViolet 400 Dye, fluorescent nanoparticles designed for use with a UV laser in flow cytometry applications.

“Cell-based flow cytometry anticipated to grow at significant CAGR during the forecast period of 2023-2028.”

Based on the technology, the flow cytometry market is cell-based and bead-based flow cytometry. Cell-based flow cytometry segment dominated the market in 2022. The dominance is attributable to the presence of technologically advanced cell-based flow cytometry products. Bead-based flow cytometry is likely to grow at a significant pace in the coming years. The rising adoption of bead-based flow cytometry and the strong emphasis of key market players on the launch of beas-based flow cytometers is likely to have a positive impact on the market growth.

“Research applications segment dominated the market in 2022.”

Based on the end user, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications. The research application dominated the segment. However, clinical application is anticipated to grow at a significant CAGR during the forecast period. Industry-academia collaborations for clinical and research application is likely to impact positively on the market. For instance, in March 2023, BD and Agency for Science, Technology, and Research (A*STAR), Singapore, extended a research partnership that will help focus on deep immunophenotyping of human tissues using spectral flow cytometry panels to bring forth discoveries that can be translated into positive healthcare outcomes.

“North America held the dominant share in 2022.”

Geographically, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2022, North America accounted for the major share of the flow cytometry market. The dominance of the North American region is owing to various factors, such as the presence of key market players in the region and the increased adoption of flow cytometry in research applications in the region. Asia Pacific is expected to grow at a faster pace due to a rise in funding for research and the increased focus on stem cell and clinical research.

The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 70% and Demand Side 30%
•By Designation: C-level - 45%, D-level - 30%, and Others - 25%
•By Region: North America: 40%, Europe: 25%, Asia Pacific: 20%, Latin America: 10%, and the Middle East and Africa: 5%

List of Companies Profiled in the Report:
•BD (US)
•Danaher Corporation (US)
•Thermo Fisher Scientific, Inc. (US)
•Agilent Technologies, Inc. (US)
•Sony Corporation (Japan)
•Bio-Rad Laboratories, Inc. (US)
•Miltenyi Biotec (Germany)
•Enzo Biochem, Inc. (US)
•Sysmex Corporation (Japan)
•bioMérieux (France)
•Cytonome/ST, LLC (US)
•Sartorius AG (Germany)
•Cytek Biosciences (US)
•Union Biometrica, Inc. (US)
•Luminex Corporation (Italy)
•Apogee Flow Systems Ltd. (UK)
•Stratedigm, Inc. (US)
•NanoCellect Biomedical, Inc. (US)
•On-chip Biotechnologies, Co., Ltd. (Japan)
•Nexcelom Biosciences LLC. (US)
•BennuBio Inc. (US)
•Orflo Technologies (US)
•Bay Biosciences Co., Ltd. (Japan)
•BioLegend, Inc. (US)
•CytoBuoy B.V (Netherlands)

Research Coverage:
This report provides a detailed picture of the flow cytometry market. It aims at estimating the size and future growth potential of the market across different segments such as technology, product & services, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
•Analysis of key drivers (Rising incidence of HIV/AIDS and cancer, wide applications in research for drug discovery & development, use of flow cytometry in regenerative medicine, growing public-private initiatives in immunology and immuno-oncology research, technological advancements in flow cytometry instruments), restraints (High product pricing), opportunities (Emerging economies, rising focus on stem cell research, uptake of recombinant DNA technology for antibody production), and challenges (Complexities related to reagent development, shortage of skilled professionals) influencing the growth of the market.
•Product and Service Development/Innovation: Detailed insights on newly launched products and technological assessment of the flow cytometry market
•Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
•Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the flow cytometry market
•Competitive Assessment: In-depth assessment of market shares, growth strategies, and products offerings of leading players like BD (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Sony Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMérieux (France), Cytonome/ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences (US), Union Biometrica, Inc. (US), Luminex Corporation (Italy), Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), Nexcelom Biosciences LLC. (US), BennuBio Inc. (US), Orflo Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands).

Content
Table of Contents

1INTRODUCTION55
1.1STUDY OBJECTIVES55
1.2MARKET DEFINITION55
1.2.1INCLUSIONS AND EXCLUSIONS56
1.3MARKET SCOPE56
1.3.1MARKETS COVERED56
1.3.2YEARS CONSIDERED57
1.4CURRENCY CONSIDERED57
1.5RESEARCH LIMITATIONS57
1.6STAKEHOLDERS58
1.7SUMMARY OF CHANGES58
1.8RECESSION IMPACT59
2RESEARCH METHODOLOGY60
2.1RESEARCH DATA60
FIGURE 1RESEARCH DESIGN60
2.1.1SECONDARY DATA61
2.1.2PRIMARY DATA62
FIGURE 2FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES62
2.2MARKET SIZE ESTIMATION63
FIGURE 3FLOW CYTOMETRY MARKET: MARKET SIZE ESTIMATION FOR SUPPLY SIDE ANALYSIS (2022)63
FIGURE 4MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS) FOR 202264
FIGURE 5ILLUSTRATIVE EXAMPLE OF BD: REVENUE SHARE ANALYSIS (2022)64
2.2.1PRIMARY INSIGHTS66
FIGURE 6MARKET VALIDATION FROM PRIMARY EXPERTS66
2.2.2MARKET SIZE ESTIMATION METHODOLOGY66
FIGURE 7MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH66
2.3GROWTH RATE ASSUMPTIONS67
FIGURE 8FLOW CYTOMETRY MARKET: CAGR PROJECTIONS DURING FORECAST PERIOD68
FIGURE 9FLOW CYTOMETRY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES68
2.4MARKET BREAKDOWN AND DATA TRIANGULATION69
FIGURE 10DATA TRIANGULATION METHODOLOGY69
2.5STUDY ASSUMPTIONS70
2.6RISK ANALYSIS70
2.7RECESSION IMPACT ANALYSIS70
TABLE 1GLOBAL INFLATION RATE PROJECTION, 2024–2028 (% GROWTH)71
TABLE 2US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)71
TABLE 3US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)71
3EXECUTIVE SUMMARY72
FIGURE 11FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)72
FIGURE 12FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)73
FIGURE 13FLOW CYTOMETRY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)73
FIGURE 14FLOW CYTOMETRY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)74
FIGURE 15GEOGRAPHICAL SNAPSHOT OF FLOW CYTOMETRY MARKET75
4PREMIUM INSIGHTS76
4.1FLOW CYTOMETRY MARKET OVERVIEW76
FIGURE 16RISING NEED FOR RESEARCH APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET76
4.2NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE AND COUNTRY77
FIGURE 17REAGENTS & CONSUMABLES SEGMENT IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 202277
4.3FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY, 2023 VS. 202878
FIGURE 18CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD78
4.4FLOW CYTOMETRY MARKET SHARE, BY END USER78
FIGURE 19ACADEMIC & RESEARCH INSTITUTES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 202278
4.5FLOW CYTOMETRY MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES79
FIGURE 20CHINA PROJECTED TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD79
5MARKET OVERVIEW80
5.1INTRODUCTION80
5.2MARKET DYNAMICS80
FIGURE 21FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES80
5.2.1DRIVERS81
5.2.1.1Rising incidence of HIV/AIDS and cancer81
TABLE 4INCIDENCE OF HIV/AIDS, BY REGION (2022)81
TABLE 5GLOBAL CANCER INCIDENCE, 2020 VS. 204081
5.2.1.2Wide applications in research for drug discovery & development82
5.2.1.3Use of flow cytometry in regenerative medicine83
5.2.1.4Growing public-private initiatives in immunology and immuno-oncology research84
5.2.1.5Technological advancements in flow cytometry instruments85
TABLE 6KEY TECHNOLOGICAL ADVANCEMENTS (2019–2022)85
5.2.2RESTRAINTS87
5.2.2.1High product pricing87
5.2.3OPPORTUNITIES87
5.2.3.1High growth potential in emerging economies87
5.2.3.2Rising focus on stem cell research88
TABLE 7ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH (2019−2024)88
5.2.3.3Uptake of recombinant DNA technology for antibody production89
5.2.4CHALLENGES89
5.2.4.1Complexities related to reagent development89
5.2.4.2Shortage of skilled professionals89
5.3SUPPLY CHAIN ANALYSIS90
FIGURE 22DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES91
5.4VALUE CHAIN ANALYSIS91
FIGURE 23FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS91
5.5ECOSYSTEM ANALYSIS92
FIGURE 24FLOW CYTOMETRY MARKET: ECOSYSTEM MAP92
5.5.1ECOSYSTEM ROLE92
5.6REGULATORY ASSESSMENT93
5.6.1STRINGENT FDA REQUIREMENTS93
5.6.2ANALYTE-SPECIFIC REAGENT RULE93
5.6.3LIMITATIONS IN VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS93
5.6.4ABSENCE OF GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS93
5.6.5IVD CE MARK APPROVALS94
5.6.6NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS94
TABLE 8NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS94
5.6.7EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS95
TABLE 9EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER BODIES95
5.6.8ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS96
TABLE 10ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS96
5.6.9LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS97
TABLE 11LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS97
5.6.10MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS97
TABLE 12MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS97
5.7PORTER’S FIVE FORCES ANALYSIS98
TABLE 13FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS98
5.7.1INTENSITY OF COMPETITIVE RIVALRY98
5.7.2BARGAINING POWER OF SUPPLIERS98
5.7.3BARGAINING POWER OF BUYERS99
5.7.4THREAT OF SUBSTITUTES99
5.7.5THREAT OF NEW ENTRANTS99
5.8PATENT ANALYSIS100
5.8.1LIST OF MAJOR PATENTS101
5.9TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES102
FIGURE 25RISING USE OF FLOW CYTOMETRY IN CLINICAL APPLICATIONS TO DRIVE MARKET102
5.10PRICING ANALYSIS102
5.10.1AVERAGE SELLING PRICE OF FLOW CYTOMETERS, BY TYPE102
TABLE 14COST OF FLOW CYTOMETERS, BY TYPE102
5.10.2COST OF FLOW CYTOMETERS AND OTHER PRODUCTS, BY KEY PLAYERS103
TABLE 15COST OF FLOW CYTOMETERS AND OTHER PRODUCTS, BY KEY PLAYERS103
5.10.3COST OF FLOW CYTOMETRY SOFTWARE103
5.10.4AVERAGE SELLING PRICE FOR FLOW CYTOMETRY INSTRUMENTS103
5.11KEY CONFERENCES AND EVENTS104
TABLE 16FLOW CYTOMETRY MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024)104
5.12TRADE DATA104
TABLE 17IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017-2021 (USD THOUSAND)104
TABLE 18EXPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND)105
TABLE 19IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2022 (USD THOUSAND)106
TABLE 20EXPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2022 (USD THOUSAND)107
5.13KEY STAKEHOLDERS AND BUYING CRITERIA108
FIGURE 26KEY STAKEHOLDERS IN BUYING PROCESS108
FIGURE 27KEY BUYING CRITERIA FOR FLOW CYTOMETRY PRODUCTS AMONG END USERS109
6FLOW CYTOMETRY MARKET, BY TECHNOLOGY110
6.1INTRODUCTION111
TABLE 21FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)111
6.2CELL-BASED FLOW CYTOMETRY111
6.2.1RISING R&D INVESTMENTS FOR NEW THERAPEUTIC AGENTS TO DRIVE MARKET111
TABLE 22CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2021–2028 (USD MILLION)112
TABLE 23NORTH AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)112
TABLE 24EUROPE: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)113
TABLE 25ASIA PACIFIC: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)113
TABLE 26LATIN AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)114
6.3BEAD-BASED FLOW CYTOMETRY114
6.3.1ABILITY TO OFFER HIGH RELIABILITY AND CONSISTENT MEASUREMENT TO SUPPORT MARKET GROWTH114
FIGURE 28BEAD-BASED FLOW CYTOMETRY MARKET: MARKET SHARE ANALYSIS (2022)115
TABLE 27BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2021–2028 (USD MILLION)115
TABLE 28NORTH AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)116
TABLE 29EUROPE: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)116
TABLE 30ASIA PACIFIC: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)117
TABLE 31LATIN AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)117
7FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE118
7.1INTRODUCTION119
TABLE 32FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)119
7.2REAGENTS & CONSUMABLES119
7.2.1RECURRING REQUIREMENT OF CONSUMABLES AND DEVELOPMENT OF HIGH-QUALITY REAGENTS TO DRIVE MARKET119
TABLE 33FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)120
TABLE 34NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)120
TABLE 35EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)121
TABLE 36ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)121
TABLE 37LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)122
7.3INSTRUMENTS122
TABLE 38FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)123
TABLE 39FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)123
TABLE 40NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)123
TABLE 41EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)124
TABLE 42ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)124
TABLE 43LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)125
7.3.1CELL ANALYZERS125
TABLE 44FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY PRICE RANGE, 2021–2028 (USD MILLION)126
TABLE 45FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)126
TABLE 46NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)127
TABLE 47EUROPE: FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)127
TABLE 48ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)128
TABLE 49LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)128
7.3.1.1High-range cell analyzers129
7.3.1.1.1Advantages of higher sensitivity and accuracy to drive adoption among end users129
TABLE 50FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)129
TABLE 51NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)129
TABLE 52EUROPE: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)130
TABLE 53ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)130
TABLE 54LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)131
7.3.1.2Mid-range cell analyzers131
7.3.1.2.1Availability of compact & high-performance analyzers to support market growth131
TABLE 55FLOW CYTOMETRY MARKET FOR MID-RANGE CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)131
TABLE 56NORTH AMERICA: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)132
TABLE 57EUROPE: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)132
TABLE 58ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)133
TABLE 59LATIN AMERICA: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)133
7.3.1.3Low-range cell analyzers133
7.3.1.3.1High adoption among price-sensitive end users to propel market133
TABLE 60FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)134
TABLE 61NORTH AMERICA: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)134
TABLE 62EUROPE: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)135
TABLE 63ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)135
TABLE 64LATIN AMERICA: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)136
7.3.2CELL SORTERS136
TABLE 65FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY PRICE RANGE, 2021–2028 (USD MILLION)137
TABLE 66FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)137
TABLE 67NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)137
TABLE 68EUROPE: FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)138
TABLE 69ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)138
TABLE 70LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)139
7.3.2.1High-range cell sorters139
7.3.2.1.1High adoption among core laboratories due to procedural benefits to drive market139
TABLE 71FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)139
TABLE 72NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)140
TABLE 73EUROPE: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)140
TABLE 74ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)141
TABLE 75LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)141
7.3.2.2Mid-range cell sorters141
7.3.2.2.1Cost-efficiency and frequent product launches to drive market141
TABLE 76FLOW CYTOMETRY MARKET FOR MID-RANGE CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)142
TABLE 77NORTH AMERICA: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)142
TABLE 78EUROPE: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)143
TABLE 79ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)143
TABLE 80LATIN AMERICA: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)144
7.3.2.3Low-range cell sorters144
7.3.2.3.1Increasing use in small labs and research facilities to drive market144
TABLE 81FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)144
TABLE 82NORTH AMERICA: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)145
TABLE 83EUROPE: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)145
TABLE 84ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)145
TABLE 85LATIN AMERICA: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)146
7.4SERVICES146
7.4.1ABILITY TO ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE TO DRIVE MARKET146
TABLE 86FLOW CYTOMETRY MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION)147
TABLE 87NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)147
TABLE 88EUROPE: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)147
TABLE 89ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)148
TABLE 90LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)148
7.5SOFTWARE149
7.5.1GROWING AVAILABILITY OF TECHNOLOGICALLY ADVANCED DATA ANALYSIS SOFTWARE TO DRIVE MARKET149
TABLE 91FLOW CYTOMETRY MARKET FOR SOFTWARE, BY REGION, 2021–2028 (USD MILLION)149
7.6ACCESSORIES150
7.6.1PROCEDURAL BENEFITS OF CUSTOMIZATION AND UPGRADES TO SUPPORT MARKET GROWTH150
TABLE 92FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY REGION, 2021–2028 (USD MILLION)150
8FLOW CYTOMETRY MARKET, BY APPLICATION151
8.1INTRODUCTION152
TABLE 93FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)152
8.2RESEARCH APPLICATIONS152
TABLE 94FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)153
TABLE 95FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)153
TABLE 96NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)154
TABLE 97EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)154
TABLE 98ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)155
TABLE 99LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)155
8.2.1PHARMACEUTICAL & BIOTECHNOLOGY156
TABLE 100FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)156
TABLE 101FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)156
TABLE 102NORTH AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)157
TABLE 103EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)157
TABLE 104ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)158
TABLE 105LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)158
8.2.1.1Drug discovery159
8.2.1.1.1Growing use of phenotypic cell-based assays in drug discovery to drive market159
TABLE 106FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION)160
TABLE 107NORTH AMERICA: FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)160
TABLE 108EUROPE: FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)161
TABLE 109ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)161
TABLE 110LATIN AMERICA: FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)162
8.2.1.2Stem cell research162
8.2.1.2.1Rising incidence of cancer to propel market162
TABLE 111FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY REGION, 2021–2028 (USD MILLION)163
TABLE 112NORTH AMERICA: FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)163
TABLE 113EUROPE: FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)164
TABLE 114ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)164
TABLE 115LATIN AMERICA: FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)165
8.2.1.3In vitro toxicity testing165
8.2.1.3.1Rising need to curtail drug attrition rates to support market growth165
TABLE 116FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY REGION, 2021–2028 (USD MILLION)166
TABLE 117NORTH AMERICA: FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)166
TABLE 118EUROPE: FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)166
TABLE 119ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)167
TABLE 120LATIN AMERICA: FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)167
8.2.2IMMUNOLOGY167
8.2.2.1Increasing prevalence of infectious & autoimmune diseases to drive market167
TABLE 121FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY REGION, 2021–2028 (USD MILLION)168
TABLE 122NORTH AMERICA: FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)168
TABLE 123EUROPE: FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)169
TABLE 124ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)169
TABLE 125LATIN AMERICA: FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)170
8.2.3CELL SORTING170
8.2.3.1Development of technologically advanced cell sorters to drive market170
TABLE 126FLOW CYTOMETRY MARKET FOR CELL SORTING, BY REGION, 2021–2028 (USD MILLION)171
TABLE 127NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION)171
TABLE 128EUROPE: FLOW CYTOMETRY MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION)171
TABLE 129ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION)172
TABLE 130LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION)172
8.2.4APOPTOSIS173
8.2.4.1Wide availability of apoptosis assays to support market growth173
TABLE 131FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY REGION, 2021–2028 (USD MILLION)173
TABLE 132NORTH AMERICA: FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION)173
TABLE 133EUROPE: FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION)174
TABLE 134ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION)174
TABLE 135LATIN AMERICA: FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION)175
8.2.5CELL CYCLE ANALYSIS175
8.2.5.1Ability to detect chromosomal abnormalities to propel market175
TABLE 136FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY REGION, 2021–2028 (USD MILLION)175
TABLE 137NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)176
TABLE 138EUROPE: FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)176
TABLE 139ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)177
TABLE 140LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)177
8.2.6CELL VIABILITY178
8.2.6.1Assessing physiological characteristics of specific target cells to support market growth178
TABLE 141FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY REGION, 2021–2028 (USD MILLION)178
TABLE 142NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION)178
TABLE 143EUROPE: FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION)179
TABLE 144ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION)179
TABLE 145LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION)180
8.2.7CELL COUNTING180
8.2.7.1Ability to simultaneously analyze additional parameters with high accuracy to drive market180
TABLE 146FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY REGION, 2021–2028 (USD MILLION)181
TABLE 147NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION)181
TABLE 148EUROPE: FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION)181
TABLE 149ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION)182
TABLE 150LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION)182
8.2.8OTHER RESEARCH APPLICATIONS183
TABLE 151FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)183
TABLE 152NORTH AMERICA: FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)183
TABLE 153EUROPE: FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)184
TABLE 154ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)184
TABLE 155LATIN AMERICA: FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)184
8.3CLINICAL APPLICATIONS185
TABLE 156FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)185
TABLE 157FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)185
TABLE 158NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)186
TABLE 159EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)186
TABLE 160ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)187
TABLE 161LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)187
8.3.1CANCER188
8.3.1.1Rising use in prediction of cancer recurrence to drive market188
TABLE 162ESTIMATED NUMBER OF NEW CANCER CASES (2020 ─2040)188
TABLE 163FLOW CYTOMETRY MARKET FOR CANCER, BY REGION, 2021–2028 (USD MILLION)189
TABLE 164NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION)189
TABLE 165EUROPE: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION)189
TABLE 166ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION)190
TABLE 167LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION)190
8.3.2HEMATOLOGY191
8.3.2.1Assessment in hematopoiesis and bone marrow function to drive market191
TABLE 168FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY REGION, 2021–2028 (USD MILLION)191
TABLE 169NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)191
TABLE 170EUROPE: FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)192
TABLE 171ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)192
TABLE 172LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)193
8.3.3IMMUNODEFICIENCY DISEASES193
8.3.3.1Detection of HIV infection and analysis of antigen-specific T-cells to propel market193
TABLE 173APPLICATION OF FLOW CYTOMETRY IN DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES194
TABLE 174FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASES, BY REGION, 2021–2028 (USD MILLION)195
TABLE 175NORTH AMERICA: FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)196
TABLE 176EUROPE: FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)196
TABLE 177ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)197
TABLE 178LATIN AMERICA: FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)197
8.3.4ORGAN & TISSUE TRANSPLANTATION197
8.3.4.1Detection of specific antibodies for donor selection to drive market197
TABLE 179FLOW CYTOMETRY MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY REGION, 2021–2028 (USD MILLION)198
TABLE 180NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION)198
TABLE 181EUROPE: FLOW CYTOMETRY MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION)199
TABLE 182ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION)199
TABLE 183LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION)200
8.3.5OTHER CLINICAL APPLICATIONS200
TABLE 184FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)200
TABLE 185NORTH AMERICA: FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)201
TABLE 186EUROPE: FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)201
TABLE 187ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)201
TABLE 188LATIN AMERICA: FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)202
8.4INDUSTRIAL APPLICATIONS202
8.4.1RISING USE IN ENERGY AND FOOD & DAIRY SECTORS TO SUPPORT MARKET GROWTH202
TABLE 189FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)203
TABLE 190NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)203
TABLE 191EUROPE: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)203
TABLE 192ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)204
TABLE 193LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)204
9FLOW CYTOMETRY MARKET, BY END USER205
9.1INTRODUCTION206
TABLE 194FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION)206
9.2ACADEMIC AND RESEARCH INSTITUTES206
9.2.1GROWING USE OF FLOW CYTOMETRY IN CANCER & STEM CELL RESEARCH TO DRIVE MARKET206
TABLE 195FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)207
TABLE 196NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)208
TABLE 197EUROPE: FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)208
TABLE 198ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)209
TABLE 199LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)209
9.3HOSPITALS AND CLINICAL TESTING LABORATORIES210
9.3.1RISING USE IN CLINICAL APPLICATIONS FOR INFECTIOUS DISEASE DIAGNOSTICS TO PROPEL MARKET210
TABLE 200FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY REGION, 2021–2028 (USD MILLION)210
TABLE 201NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)211
TABLE 202EUROPE: FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)211
TABLE 203ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)212
TABLE 204LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)212
9.4PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES213
9.4.1INCREASING NUMBER OF CLINICAL TRIALS TO SUPPORT MARKET GROWTH213
TABLE 205FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)213
TABLE 206NORTH AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)214
TABLE 207EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)214
TABLE 208ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)215
TABLE 209LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)215
10FLOW CYTOMETRY MARKET, BY REGION216
10.1INTRODUCTION217
TABLE 210FLOW CYTOMETRY MARKET, BY REGION, 2021–2028 (USD MILLION)217
10.2NORTH AMERICA218
FIGURE 29NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT219
TABLE 211NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)220
TABLE 212NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)220
TABLE 213NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)220
TABLE 214NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)221
TABLE 215NORTH AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY PRICE RANGE, 2021–2028 (USD MILLION)221
TABLE 216NORTH AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY PRICE RANGE,